BrainBlog

A very readable piece from Gina Kolata of the New York Times: Doubt on Tactic in Alzheimer’s Battle By GINA KOLATA The New York Times Published: August 18, 2010 "The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and treatment." Read the full article

Audio available from The BBC : Listen From the show's webpage: "Neurobiologist Professor Colin Blakemore was a war baby brought up in devastated Coventry. His two-up two-down home had the first TV in the street on which he lived next door to relatives and a family of ten. As an only child, his parents were able to cash in an insurance policy of £16 which enabled him to go to the local grammar school where he proved himself to be more of an artist and actor than a scientist. Producer: Smita Patel."

From FierceBiotech FDA panel backs new epilepsy drug from GSK, Valeant August 12, 2010 — 7:41am ET By John Carroll "GlaxoSmithKline and Valeant got a solid endorsement for their new epilepsy drug Potiga (ezogabine) from the FDA's panel of experts, putting them on track to a likely approval. The experts unanimously agreed that the drug would benefit epilepsy patients whose meds couldn't stop seizures. And they agreed that careful monitoring would flag patients who experience an inability to urinate while taking the drug." Read the full article

From The New York Times Patricia Neal, an Oscar Winner Who Endured Tragedy, Dies at 84 By ALJEAN HARMETZ Published: August 9, 2010 Patricia Neal

Available for viewing and downloading from the NIH: It Takes Tau to Tangle : Plaques, Tangles and Neurodegenerative Disease by Karen Duff 23 June 2010 link